SEC Form 4 · accession 0001179110-17-007876
Theravance Biopharma, Inc. · TBPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Renee D Gala
Officer — SVP, Chief Financial Officer
Period of report
May 20, 2017
Accepted (ET)
May 23, 2017 · 7:58 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001583107
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1 | May 20, 2017 | F | 6,753 | $36.83 | D | 221,299 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Includes 1,702 shares acquired under the Theravance Biopharma, Inc. 2013 Employee Share Purchase Plan on May 15, 2017.